The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects

Journal of Experimental Medicine

Volumn 207, Issue 1, 2010, Pages 207-221

  Oliveira, Cláudia C ^a   Van Veelen, Peter A ^a   Querido, Bianca ^a   De Ru, Arnoud ^a   Sluijter, Marjolein ^a   Laban, Sandra ^a   Van Der Burg, Sjoerd H ^a   Offringa, Rienk ^a   Van Hall, Thorbald ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY COMPLEX QA 1; NATURAL KILLER CELL RECEPTOR NKG2A; T LYMPHOCYTE RECEPTOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MICE; MICE, KNOCKOUT; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PEPTIDES;

EID: 76149118757     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091429     Document Type: Article

References (59)

1. Aldrich, C.J., A. DeCloux, A.S. Woods, R.J. Cotter, M.J. Soloski, and J. Forman. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:649-658. doi:10.1016/0092-8674(94)90550-9
2. Bijker, M.S., S.J. van den Eeden, K.L. Franken, C.J. Melief, R. Offringa, and S.H. van der Burg. 2007. CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J. Immunol. 179:5033-5040.
3. Bland, F.A., M.K. Lemberg, A.J. McMichael, B. Martoglio, and V.M. Braud. 2003. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E. J. Biol. Chem. 278:33747-33752. doi:10.1074/jbc. M305593200
4. Braud, V.M., D.S. Allan, C.A. O'Callaghan, K. Söderström, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, et al. 1998a. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:795-799. doi:10.1038/35869
5. Braud, V.M., D.S.J. Allan, D. Wilson, and A.J. McMichael. 1998b. TAPand tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1-10. doi:10.1016/S0960-9822(98) 70014-4
6. Chiang, E.Y., M. Henson, and I. Stroynowski. 2003. Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth. J. Immunol. 170:4515-4523.
7. Cotterill, L.A., H.J. Stauss, M.M. Millrain, D.J. Pappin, D. Rahman, B. Canas, P. Chandler, A. Stackpoole, E. Simpson, P.J. Robinson, and P.J. Dyson. 1997. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27:2123-2132. doi:10.1002/eji.1830270902
8. Davies, A., S. Lopez-Briones, H. Ong, C. O'Neil-Marshall, F.A. Lemonnier, K. Nagaraju, E.S. Metcalf, and M.J. Soloski. 2004. Infection-induced expansion of a MHC Class Ib-dependent intestinal intraepithelial gammadelta T cell subset. J. Immunol. 172:6828-6837.
9. DeCloux, A., A.S. Woods, R.J. Cotter, M.J. Soloski, and J. Forman. 1997. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J. Immunol. 158:2183-2191.
10. Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126. doi:10.1038/77793
11. Furukawa, H., T. Yabe, T. Akaza, K. Tadokoro, S. Tohma, T. Inoue, K. Tokunaga, K. Yamamoto, D.E. Geraghty, and T. Juji. 1999. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tissue Antigens. 53:292-295. doi:10.1034/j.1399-0039.1999.530310.x
12. García, P., M. Llano, A.B. de Heredia, C.B. Willberg, E. Caparrós, P. Aparicio, V.M. Braud, and M. López-Botet. 2002. Human T cell receptor-mediated recognition of HLA-E. Eur. J. Immunol. 32:936-944. doi:10.1002/1521-4141(200204)32:4〈936::AID-IMMU936〉3.0. CO;2-M
13. Gays, F., K.P. Fraser, J.A. Toomey, A.G. Diamond, M.M. Millrain, P.J. Dyson, and C.G. Brooks. 2001. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis. J. Immunol. 166:1601-1610.
14. Grimsley, C., A. Kawasaki, C. Gassner, N. Sageshima, Y. Nose, K. Hatake, D.E. Geraghty, and A. Ishitani. 2002. Definitive high resolution typing of HLA-E allelic polymorphisms: identifying potential errors in existing allele data. Tissue Antigens. 60:206-212. doi:10.1034/j.1399-0039.2002.600302.x
15. Heinzel, A.S., J.E. Grotzke, R.A. Lines, D.A. Lewinsohn, A.L. McNabb, D.N. Streblow, V.M. Braud, H.J. Grieser, J.T. Belisle, and D.M. Lewinsohn. 2002. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J. Exp. Med. 196:1473-1481. doi:10.1084/ jem.20020609
16. Hermel, E., A.J. Hart, I. Gunduz, H. Acton, C. Kim, M. Wurth, S. Uddin, C. Smith, K. Fischer Lindahl, and C.J. Aldrich. 2004. Polymorphism and conservation of the genes encoding Qa1 molecules. Immunogenetics. 56:639-649. doi:10.1007/s00251-004-0722-x
17. Howell, D., J.M. Levitt, P.A. Foster, M.M. Guenther, S.M. Shawar, R.R. Rich, and J.R. Rodgers. 2000. Heterogeneity of RMA-S cell line: derivatives of RMA-S cells lacking H2-Kb and H2-Db expression. Immunogenetics. 52:150-154. doi:10.1007/s002510000254
18. Jensen, P.E., B.A. Sullivan, L.M. Reed-Loisel, and D.A. Weber. 2004. Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity. Immunol. Res. 29:81-92. doi:10.1385/ IR:29:1-3:081
19. + T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185-216. doi:10.1146/annurev.immunol.18.1. 185
20. Kaiser, B.K., J.C. Pizarro, J. Kerns, and R.K. Strong. 2008. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc. Natl. Acad. Sci. USA. 105:6696-6701. doi:10.1073/pnas.0802736105
21. Kambayashi, T., J.R. Kraft-Leavy, J.G. Dauner, B.A. Sullivan, O. Laur, and P.E. Jensen. 2004. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. J. Immunol. 172:1661-1669.
22. Kraft, J.R., R.E. Vance, J. Pohl, A.M. Martin, D.H. Raulet, and P.E. Jensen. 2000. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J. Exp. Med. 192:613-624. doi:10.1084/jem.192.5.613
23. Kurepa, Z., C.A. Hasemann, and J. Forman. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188:973-978. doi:10.1084/jem.188.5.973
24. Lee, N., D.R. Goodlett, A. Ishitani, H. Marquardt, and D.E. Geraghty. 1998. HLA-E surface expression depends on binding of TAPdependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951-4960.
25. Lemberg, M.K., F.A. Bland, A. Weihofen, V.M. Braud, and B. Martoglio. 2001. Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes. J. Immunol. 167:6441-6446.
26. Li, L., B.A. Sullivan, C.J. Aldrich, M.J. Soloski, J. Forman, A.G. Grandea III, P.E. Jensen, and L. Van Kaer. 2004. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs. J. Immunol. 173:3707-3715.
27. Ljunggren, H.G., and K. Kärre. 1990. In search of the 'missing self ': MHC molecules and NK cell recognition. Immunol. Today. 11:237-244. doi:10.1016/0167-5699(90)90097-S
28. Lo, W.-F., A.S. Woods, A. DeCloux, R.J. Cotter, E.S. Metcalf, and M.J. Soloski. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat. Med. 6:215-218. doi:10.1038/72329
29. Lo Monaco, E., L. Sibilio, E. Melucci, E. Tremante, M. Suchànek, V. Horejsi, A. Martayan, and P. Giacomini. 2008. HLA-E: strong association with β2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides. J. Immunol. 181:5442-5450.
30. Lu, L., M.B.F. Werneck, and H. Cantor. 2006. The immunoregulatory effects of Qa-1. Immunol. Rev. 212:51-59. doi:10.1111/j.0105-2896.2006.00418.x
31. Martoglio, B., and B. Dobbertein. 1998. Signal sequences: more than just greasy peptides. Trends Cell Biol. 8:410-415.
32. McMahon, C.W., and D.H. Raulet. 2001. Expression and function of NK cell receptors in CD8+ T cells. Curr. Opin. Immunol. 13:465-470. doi:10.1016/S0952-7915(00)00242-9
33. Michaëlsson, J., C. Teixeira de Matos, A. Achour, L.L. Lanier, K. Kärre, and K. Söderström. 2002. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196:1403-1414. doi:10.1084/jem.20020797
34. Miller, J.D., D.A. Weber, C. Ibegbu, J. Pohl, J.D. Altman, and P.E. Jensen. 2003. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J. Immunol. 171:1369-1375.
35. O'Callaghan, C.A., J. Tormo, B.E. Willcox, V.M. Braud, B.K. Jakobsen, D.I. Stuart, A.J. McMichael, J.I. Bell, and E.Y. Jones. 1998. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell. 1:531-541. doi:10.1016/S1097-2765(00)80053-2
36. Palmisano, G.L., E. Contardi, A. Morabito, V. Gargaglione, G.B. Ferrara, and M.P. Pistillo. 2005. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines. Hum. Immunol. 66:1-12. doi:10.1016/ j.humimm.2004.10.006
37. Pérarnau, B., M.F. Saron, B.R. San Martin, N. Bervas, H. Ong, M.J. Soloski, A.G. Smith, J.M. Ure, J.E. Gairin, and F.A. Lemonnier. 1999. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29:1243-1252. doi:10.1002/(SICI)1521-4141(199904)29:04〈1243:: AID-IMMU1243〉3.0.CO;2-A
38. Petrie, E.J., C.S. Clements, J. Lin, L.C. Sullivan, D. Johnson, T. Huyton, A. Heroux, H.L. Hoare, T. Beddoe, H.H. Reid, et al. 2008. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 205:725-735. doi:10.1084/jem.20072525
39. Robinson, P.J., P.J. Travers, A. Stackpoole, L. Flaherty, and H. Djaballah. 1998. Maturation of Qa-1b class I molecules requires β 2-microglobulin but is TAP independent. J. Immunol. 160:3217-3224.
40. Rodgers, J.R., and R.G. Cook. 2005. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5:459-471. doi:10.1038/ nri1635
41. Rodolfo, M., C. Castelli, C. Bassi, P. Accornero, M. Sensi, and G. Parmiani. 1994. Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors. Int. J. Cancer. 57:440-447. doi:10.1002/ijc.2910570324
42. Romagnani, C., G. Pietra, M. Falco, E. Millo, P. Mazzarino, R. Biassoni, A. Moretta, L. Moretta, and M.C. Mingari. 2002. Identification of HLAE-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc. Natl. Acad. Sci. USA. 99:11328-11333. doi:10.1073/pnas.172369799
43. Rudolph, M.G., and I.A. Wilson. 2002. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14:52-65. doi:10.1016/S0952-7915(01) 00298-9
44. Seaman, M.S., B. Pérarnau, K.F. Lindahl, F.A. Lemonnier, and J. Forman. 1999. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules. J. Immunol. 162:5429-5436.
45. Snyder, H.L., I. Bacík, J.W. Yewdell, T.W. Behrens, and J.R. Bennink. 1998. Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway. Eur. J. Immunol. 28:1339-1346. doi:10.1002/(SICI)1521-4141(199804)28:04〈1339:: AID-IMMU1339〉3.0.CO;2-B
46. Strong, R.K., M.A. Holmes, P. Li, L. Braun, N. Lee, and D.E. Geraghty. 2003. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278:5082-5090. doi:10.1074/jbc.M208268200
47. Sullivan, B.A., P. Kraj, D.A. Weber, L. Ignatowicz, and P.E. Jensen. 2002. Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity. 17:95-105. doi:10.1016/S1074-7613(02)00343-6
48. Suri, A., J.J. Walters, M.G. Levisetti, M.L. Gross, and E.R. Unanue. 2006. Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. Eur. J. Immunol. 36:544-557. doi:10.1002/eji.200526235
49. Tang, X., I. Maricic, N. Purohit, B. Bakamjian, L.M. Reed-Loisel, T. Beeston, P. Jensen, and V. Kumar. 2006. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+ T cells. J. Immunol. 177:7645-7655.
50. Ureta-Vidal, A., H. Firat, B. Pérarnau, and F.A. Lemonnier. 1999. Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice. J. Immunol. 163:2555-2560.
51. Valés-Gómez, M., H.T. Reyburn, R.A. Erskine, M. López-Botet, and J.L. Strominger. 1999. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:4250-4260. doi:10.1093/emboj/ 18.15.4250
52. van Hall, T., J. van Bergen, P.A. van Veelen, M. Kraakman, L.C. Heukamp, F. Koning, C.J.M. Melief, F. Ossendorp, and R. Offringa. 2000. Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin. J. Immunol. 165:869-877.
53. van Hall, T., E.Z. Wolpert, P. van Veelen, S. Laban, M. van der Veer, M. Roseboom, S. Bres, P. Grufman, A. de Ru, H. Meiring, et al. 2006. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat. Med. 12:417-424. doi:10.1038/nm1381
54. van Hall, T., S. Laban, D. Koppers-Lalic, J. Koch, C. Precup, P. Asmawidjaja, R. Offringa, and E.J. Wiertz. 2007. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1. J. Immunol. 178:657-662.
55. b) by putative activating receptors CD94/ NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190:1801-1812. doi:10.1084/jem.190.12.1801
56. Vugmeyster, Y., R. Glas, B. Pérarnau, F.A. Lemonnier, H. Eisen, and H. Ploegh. 1998. Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. Proc. Natl. Acad. Sci. USA. 95:12492-12497. doi:10.1073/ pnas.95.21.12492
57. Vyas, J.M., A.G. Van der Veen, and H.L. Ploegh. 2008. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 8:607-618. doi:10.1038/nri2368
58. Weinzierl, A.O., D. Rudolf, N. Hillen, S. Tenzer, P. Van Endert, H. Schild, H.G. Rammensee, and S. Stevanovic. 2008. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry. Eur. J. Immunol. 38:1-8. doi:10.1002/eji.200838136
59. Yang, J.C., and D. Perry-Lalley. 2000. The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors. J. Immunother. 23:177-183. doi:10.1097/00002371-200003000- 00001